BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2059-0105

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children ; volume:7 ; number:1 ; day:3 ; month:12 ; year:2022 ; pages:1-10 ; date:12.2022
npj vaccines ; 7, Heft 1 (3.12.2022), 1-10, 12.2022

Creator: Bartsch, Yannic C.
Chen, Jessica W.
Kang, Jaewon
Burns, Madeleine D.
Denis, Kerri J. St
Sheehan, Maegan L.
Davis, Jameson P.
Edlow, Andrea G.
Balazs, Alejandro B.
Yonker, Lael M.
Alter, Galit

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41541-022-00575-w

URN: urn:nbn:de:101:1-2023021421232568803143

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:51 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bartsch, Yannic C.
Chen, Jessica W.
Kang, Jaewon
Burns, Madeleine D.
Denis, Kerri J. St
Sheehan, Maegan L.
Davis, Jameson P.
Edlow, Andrea G.
Balazs, Alejandro B.
Yonker, Lael M.
Alter, Galit
SpringerLink (Online service)

Other Objects (12)

Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Hochschulschrift

Heme induces trained immunity

Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisation

Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant

BNT162b2 booster vaccination elicits cross-reactive immunity against SARS-CoV-2 variants B.1.1.529 and B.1.617.2 in convalescents of all ages

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection

Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity

BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?

Delta (B1.617.2) variant of SARS-CoV-2 induces severe neurotropic patterns in K18-hACE2 mice

Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Hochschulschrift

Heme induces trained immunity

Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisation

Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant

BNT162b2 booster vaccination elicits cross-reactive immunity against SARS-CoV-2 variants B.1.1.529 and B.1.617.2 in convalescents of all ages

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection

Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity

BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?

Delta (B1.617.2) variant of SARS-CoV-2 induces severe neurotropic patterns in K18-hACE2 mice

Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Hochschulschrift

Heme induces trained immunity

Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisation

Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant

BNT162b2 booster vaccination elicits cross-reactive immunity against SARS-CoV-2 variants B.1.1.529 and B.1.617.2 in convalescents of all ages

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection

Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity

BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?

Delta (B1.617.2) variant of SARS-CoV-2 induces severe neurotropic patterns in K18-hACE2 mice

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Heme induces trained immunity

Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisation

Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant

BNT162b2 booster vaccination elicits cross-reactive immunity against SARS-CoV-2 variants B.1.1.529 and B.1.617.2 in convalescents of all ages

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection

Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity

BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?

Delta (B1.617.2) variant of SARS-CoV-2 induces severe neurotropic patterns in K18-hACE2 mice

Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Heme induces trained immunity

Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisation

Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant

BNT162b2 booster vaccination elicits cross-reactive immunity against SARS-CoV-2 variants B.1.1.529 and B.1.617.2 in convalescents of all ages

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection

Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity

BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?

Delta (B1.617.2) variant of SARS-CoV-2 induces severe neurotropic patterns in K18-hACE2 mice

Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Heme induces trained immunity

Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisation

Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant

BNT162b2 booster vaccination elicits cross-reactive immunity against SARS-CoV-2 variants B.1.1.529 and B.1.617.2 in convalescents of all ages

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection

Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity

BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?

Delta (B1.617.2) variant of SARS-CoV-2 induces severe neurotropic patterns in K18-hACE2 mice

Related objects

Reset password